# acetaminophen, dextromethorphan HBr, doxylamine succinate (acetaminophen, dextromethorphan HBr, doxylamine succinate) by Haleon US Holdings LLC: new drug for further processing listing

**Launch Signal Score:** 15/100

| Field | Value |
|---|---|
| Generic name | acetaminophen, dextromethorphan HBr, doxylamine succinate |
| NDC | 0031-8989 |
| Labeler | Haleon US Holdings LLC |
| Product type | DRUG FOR FURTHER PROCESSING |
| Approval pathway | DRUG FOR FURTHER PROCESSING |
| Dosage form | SYRUP |
| Active ingredients | ACETAMINOPHEN 650 mg/20mL; DEXTROMETHORPHAN HYDROBROMIDE 30 mg/20mL; DOXYLAMINE SUCCINATE 12.5 mg/20mL |
| Marketing start | 2026-08-21 |
| Package configurations | 1 |

## Why this score


Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=0031-8989). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.